Human Endothelial Cells Produce IL‐6: Lack of Responses to Exogenous IL‐6

Annals of the New York Academy of Sciences

Volumn 557, Issue 1, 1989, Pages 374-387

  PODOR, THOMAS J ^a   JIRIK, FRANK R ^a   LOSKUTOFF, DAVID J ^a   CARSON, DENNIS A ^a   LOTZ, MARTIN ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; RADIOISOTOPE;

CELL CULTURE; CELL FUNCTION; CELL GROWTH; ENDOTHELIUM CELL; HUMAN; IMMUNOPRECIPITATION; PRIORITY JOURNAL;

ANIMAL; BIOLOGICAL FACTORS; CELL DIVISION; CELL LINE; CELLS, CULTURED; CYTOKINES; DNA REPLICATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN; INTERLEUKIN-6; INTERLEUKINS; MACROPHAGES; MICE; PLASMACYTOMA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; UMBILICAL VEINS;

EID: 0024382959     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1989.tb24030.x     Document Type: Article

References (29)

1. Leukocyte‐endothelial interactions
2. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant gene in human endothelial cells and dermal fibroblasts
3. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA‐A,B antigens in vascular endothelial cells and dermal fibroblasts in virro
4. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1
5. Endotoxin and tumor necrosis factor induce interleukin‐1 gene expression in adult human vascular endothelial cells
6. Interleukin 1 stimulates human endothelial cells to produce granulocyte‐macrophage colony‐stimulating factor and granulocyte colony‐stimulating factor
7. Structural analysis of the sequence coding for an inducible 26‐kDa protein in human fibroblasts
8. Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies
9. Complementary DNA for a novel interleukin that induces B lymphocytes to produce immunoglobulin
10. Identification of the human 26‐kD protein. interferon beta‐2 (IFN‐beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor
11. B‐cell stimulatory factors (BSF's): molecular structure, biological functions, and regulation of expression
12. Interferon beta‐2/B cell stimulatory factor type 2 shares identity with monocyte‐derived hepatocyte‐ stimulating factor and regulates the major acute phase protein response in liver cells
13. B‐cell‐stimulatory factor 2 (beta‐2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells
14. Auto‐anti‐idiotype: a basis for autoimmunity and a strategy for anti‐receptor antibodies
15. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes
16. Interleukin 6 enhancement of interleukin 3‐dependent proliferation of multipotential hemopoietic progenitors
17. Culture of vascular endothelium
18. Absence of antiviral activity in recombinant B cell stirnulatory factor 2 (BSF‐2)
19. A macrophage‐derived factor required by plasmacytomas for survival and proliferation in vitro
20. T cell‐replacing factor (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF
21. Two different rheumatoid factor‐producing cell populations distinguished by the mouse erythrocyte receptor and responsiveness to polyclonal B cell activators
22. Cytokine activation of vascular endothelium
23. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines
24. Human endothelial culture supernatant (HECS): evidence for a growth‐promoting factor binding to hybridoma and myeloma cells
25. Induction of beta 2‐interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation
26. A cytokine network in human diploid fibroblasts: interactions of beta‐interferons, tumor necrosis factor, platelet‐derived growth factor, and interleukin‐1
27. Autocrine generation and requirement of BSF‐2/IL‐6 for human multiple myelomas
28. Serum levels of interleukin‐6 and acute phase responses